UNII Q40Q9N063P

ACETIC ACID

Unique Ingredient Identifier Q40Q9N063P is listed as a ingredient substance
UniiQ40Q9N063P
Preferred Substance NameACETIC ACID
Rn64-19-7
Ec200-580-7
NcitC61623
Rxcui168
Pubchem176
Molecular FormulaC2H4O2
InchikeyQTBSBXVTEAMEQO-UHFFFAOYSA-N
SmilesCC(O)=O
Unii TypeINGREDIENT SUBSTANCE
RN64-19-7
EC200-580-7
NCITC61623
RXCUI168
PUBCHEM176
MFC2H4O2
INCHI KEYQTBSBXVTEAMEQO-UHFFFAOYSA-N
SMILESCC(O)=O

Alternate Names

Dosage Forms

UNII Q40Q9N063P ACETIC ACID is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION NA
AURICULAR (OTIC)SUSPENSION ADJ PH
AURICULAR (OTIC)SUSPENSION, LIQUID0.26 %
EXTRACORPOREALSOLUTION0.12 %
IM - IVINJECTION0.25 %
IM - IV - SCINJECTION0.35 %
IM - IV - SCPOWDER, FOR INJECTION SOLUTION ADJ PH
IM - SCINJECTION0.2 %
IM - SCINJECTION, SUSTAINED ACTION ADJ PH
INJECTIONINJECTABLE ADJ PH
INTRA-ARTICULARINJECTION ADJ PH
INTRALESIONALINJECTION ADJ PH
INTRAMUSCULARINJECTION0.25 %W/V
INTRAMUSCULARINJECTION ADJ PH
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJ PH
INTRASYNOVIALINJECTION ADJ PH
INTRATRACHEALSUSPENSION ADJ PH
INTRAVENOUSINJECTABLE0.1 %
INTRAVENOUSINJECTABLE ADJ PH
INTRAVENOUSINJECTION0.27 %
INTRAVENOUSINJECTION0.2 %
INTRAVENOUSINJECTION0.2 %
INTRAVENOUSINJECTION ADJ PH
INTRAVENOUSINJECTION, SOLUTION5.4 ug/1mL
INTRAVENOUSINJECTION, SOLUTION0.009 %
INTRAVENOUSINJECTION, SOLUTION ADJ PH
INTRAVENOUSLIQUID, WATER, STERILE, FOR INJECTION0.01 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJ PH
INTRAVENOUSSOLUTION ADJ PH
INTRAVENOUSSOLUTION, INJECTION0.4 %W/V
IRRIGATIONSOLUTION ADJ PH
IV - SCINJECTION0.2 %
IV - SCLIQUID0.2 %
IV(INFUSION)INJECTABLE0.14 %
IV(INFUSION)INJECTION1 %
IV(INFUSION)INJECTION ADJ PH
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.27 %
IV(INFUSION)SOLUTION, INJECTION0.055 %
NASALSOLUTION NA
NASALSPRAY, METERED0.12 %W/V
NERVE BLOCKINJECTION NA
OPHTHALMICPOWDER, FOR SOLUTION ADJ PH
OPHTHALMICSOLUTION0.08 %
OPHTHALMICSOLUTION, DROPS0.09 %
ORALCAPSULE NA
ORALCAPSULE, ENTERIC COATED PELLETS0.36 MG
ORALCAPSULE, HARD GELATIN NA
ORALCONCENTRATE NA
ORALSOLUTION5 MG/5ML
ORALSOLUTION, ELIXIR1.07 MG/5ML
ORALSOLUTION, INJECTION ADJ PH
ORALSOLUTION, SYRUP13.2 MG/5ML
ORALSYRUP0.2 %
ORALTABLET0.002 MG
OTICSUSPENSION0.04 %
PARENTERALINJECTION ADJ PH
PHOTOPHERESISSOLUTION0.12 %
SOFT TISSUEINJECTION ADJ PH
SUBCUTANEOUSINJECTABLE0.2 %
SUBCUTANEOUSINJECTION0.2 %
SUBCUTANEOUSLIQUID0.011 %
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.041 %
SUBCUTANEOUSSOLUTION0.15 %
SUBCUTANEOUSSOLUTION, INJECTION0.11 %
SUBMUCOSALSOLUTION, INJECTION ADJ PH
TOPICALEMULSION, CREAM NA
TOPICALSOLUTION0.043 %
TOPICALSPONGE NA
VAGINALEMULSION, AEROSOL FOAM0.025 %

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.